Skip to main content
. 2021 Mar 22;29(1):45–52. doi: 10.12793/tcp.2021.29.e4

Table 3. Adverse drug reactions occurred after a single administration of tenofovir disoproxil phosphate (292 mg) and tenofovir disoproxil fumarate (300 mg).

Adverse events Tenofovir disoproxil phosphate (n = 38) Tenofovir disoproxil fumarate (n = 37) Total (n = 38)
Total 2 (5.26) [3] 2 (5.41) [4] 4 (10.53) [7]
Dyspepsia 0 (0.00) [0] 1 (2.70) [1] 1 (2.63) [1]
Diarrhoea 1 (2.63) [1] 0 (0.00) [0] 1 (2.63) [1]
Headache 1 (2.63) [1] 2 (5.41) [2] 3 (7.89) [3]
Ocular discomfort 0 (0.00) [0] 1 (2.70) [1] 1 (2.63) [1]
Myalgia 1 (2.63) [1] 0 (0.00) [0] 1 (2.63) [1]

Percentages are based on the subjects within each treatment group. Data are presented as number (%) [case].